{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:23:47Z","timestamp":1792783427084,"version":"4.5.0"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T00:00:00Z","timestamp":1789776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T00:00:00Z","timestamp":1789776000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"name":"Universit\u00e0 degli Studi di Verona","id":[{"id":"https:\/\/ror.org\/039bp8j42","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Drug Saf"],"DOI":"10.1007\/s40264-026-01733-y","type":"journal-article","created":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T16:56:34Z","timestamp":1789836994000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["A Text-Mining Algorithm for Identifying Drug Pairs Potentially Involved in Prescribing Cascades: Development and Internal Validation Within the Prescribing Inappropriateness Assessment (PINA) Digital Tool"],"prefix":"10.1007","author":[{"given":"Massimo","family":"Carollo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Forti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salvatore","family":"Crisafulli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"L\u2019Abbate","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irene","family":"Cristini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federica","family":"Soardo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marilisa Giustina","family":"Stano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Bellantuono","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Davide","family":"Benetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Riccardo","family":"Lora","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1147-7296","authenticated-orcid":false,"given":"Gianluca","family":"Trifir\u00f2","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,19]]},"reference":[{"issue":"8","key":"1733_CR1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0255642","volume":"16","author":"EH Young","year":"2021","unstructured":"Young EH, Pan S, Yap AG, Reveles KR, Bhakta K. Polypharmacy prevalence in older adults seen in United States physician offices from 2009 to 2016. PLoS ONE. 2021;16(8):e0255642. https:\/\/doi.org\/10.1371\/journal.pone.0255642.","journal-title":"PLoS ONE"},{"key":"1733_CR2","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/j.archger.2018.06.018","volume":"78","author":"L Mid\u00e3o","year":"2018","unstructured":"Mid\u00e3o L, Giardini A, Menditto E, Kardas P, Costa E. Polypharmacy prevalence among older adults based on the survey of health, ageing and retirement in Europe. Arch Gerontol Geriatr. 2018;78:213\u201320. https:\/\/doi.org\/10.1016\/j.archger.2018.06.018.","journal-title":"Arch Gerontol Geriatr"},{"issue":"1","key":"1733_CR3","doi-asserted-by":"publisher","DOI":"10.1186\/s12877-017-0621-2","volume":"17","author":"N Masnoon","year":"2017","unstructured":"Masnoon N, Shakib S, Kalisch-Ellett L, Caughey GE. What is polypharmacy? A systematic review of definitions. BMC Geriatr. 2017;17(1):230. https:\/\/doi.org\/10.1186\/s12877-017-0621-2.","journal-title":"BMC Geriatr"},{"key":"1733_CR4","doi-asserted-by":"publisher","DOI":"10.3389\/fdsfr.2022.1011701","volume":"2","author":"S Crisafulli","year":"2022","unstructured":"Crisafulli S, Poluzzi E, Lunghi C, et al. Deprescribing as a strategy for improving safety of medicines in older people: clinical and regulatory perspective. Front Drug Saf. 2022;2:1011701. https:\/\/doi.org\/10.3389\/fdsfr.2022.1011701.","journal-title":"Front Drug Saf Regul"},{"issue":"1","key":"1733_CR5","doi-asserted-by":"publisher","DOI":"10.1007\/s40520-023-02679-2","volume":"36","author":"M Carollo","year":"2024","unstructured":"Carollo M, Boccardi V, Crisafulli S, et al. Medication review and deprescribing in different healthcare settings: a position statement from an Italian scientific consortium. Aging Clin Exp Res. 2024;36(1):63. https:\/\/doi.org\/10.1007\/s40520-023-02679-2.","journal-title":"Aging Clin Exp Res"},{"issue":"5","key":"1733_CR6","doi-asserted-by":"publisher","first-page":"375","DOI":"10.2165\/00002512-200522050-00003","volume":"22","author":"L Merle","year":"2005","unstructured":"Merle L, Laroche ML, Dantoine T, Charmes JP. Predicting and preventing adverse drug reactions in the very old. Drugs Aging. 2005;22(5):375\u201392. https:\/\/doi.org\/10.2165\/00002512-200522050-00003.","journal-title":"Drugs Aging"},{"issue":"6","key":"1733_CR7","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1007\/s40266-025-01201-9","volume":"42","author":"R Daunt","year":"2025","unstructured":"Daunt R, McGettigan S, Kelly L, Curtin D, O\u2019Mahony D. Detection of potential prescribing cascades in multimorbid older patients hospitalised with acute illness\u2014an observational prospective prevalence study. Drugs Aging. 2025;42(6):535\u201346. https:\/\/doi.org\/10.1007\/s40266-025-01201-9.","journal-title":"Drugs Aging"},{"issue":"7","key":"1733_CR8","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1007\/s40266-021-00868-0","volume":"38","author":"EJ Morris","year":"2021","unstructured":"Morris EJ, Brown JD, Manini TM, Vouri SM. Differences in health-related quality of life among adults with a potential dihydropyridine calcium channel blocker-loop diuretic prescribing cascade. Drugs Aging. 2021;38(7):625\u201332. https:\/\/doi.org\/10.1007\/s40266-021-00868-0.","journal-title":"Drugs Aging"},{"issue":"2","key":"1733_CR9","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1111\/jgs.18683","volume":"72","author":"PA Rochon","year":"2024","unstructured":"Rochon PA, Austin PC, Normand SL, et al. Association of a calcium channel blocker and diuretic prescribing cascade with adverse events: a population-based cohort study. J Am Geriatr Soc. 2024;72(2):467\u201378. https:\/\/doi.org\/10.1111\/jgs.18683.","journal-title":"J Am Geriatr Soc"},{"issue":"12","key":"1733_CR10","doi-asserted-by":"publisher","first-page":"e2545274","DOI":"10.1001\/jamanetworkopen.2025.45274","volume":"8","author":"ME Growdon","year":"2025","unstructured":"Growdon ME, Tjota N, Campbell R, et al. Decision-making and downstream outcomes of the gabapentinoid-diuretic prescribing cascade. JAMA Netw Open. 2025;8(12):e2545274. https:\/\/doi.org\/10.1001\/jamanetworkopen.2025.45274.","journal-title":"JAMA Netw Open"},{"issue":"5","key":"1733_CR11","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1111\/jgs.15800","volume":"67","author":"LM McCarthy","year":"2019","unstructured":"McCarthy LM, Visentin JD, Rochon PA. Assessing the scope and appropriateness of prescribing cascades. J Am Geriatr Soc. 2019;67(5):1023\u20136. https:\/\/doi.org\/10.1111\/jgs.15800.","journal-title":"J Am Geriatr Soc"},{"issue":"8966","key":"1733_CR12","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/s0140-6736(95)92656-9","volume":"346","author":"PA Rochon","year":"1995","unstructured":"Rochon PA, Gurwitz JH. Drug therapy. Lancet. 1995;346(8966):32\u20136. https:\/\/doi.org\/10.1016\/s0140-6736(95)92656-9.","journal-title":"Lancet"},{"issue":"7115","key":"1733_CR13","doi-asserted-by":"publisher","first-page":"1096","DOI":"10.1136\/bmj.315.7115.1096","volume":"315","author":"PA Rochon","year":"1997","unstructured":"Rochon PA, Gurwitz JH. Optimising drug treatment for elderly people: the prescribing cascade. BMJ. 1997;315(7115):1096\u20139. https:\/\/doi.org\/10.1136\/bmj.315.7115.1096.","journal-title":"BMJ"},{"issue":"5","key":"1733_CR14","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1007\/s40266-026-01295-9","volume":"43","author":"M Carollo","year":"2026","unstructured":"Carollo M, Crisafulli S, Zerio M, et al. Prescribing cascades: an umbrella review and updated systematic review. Drugs Aging. 2026;43(5):397\u2013424. https:\/\/doi.org\/10.1007\/s40266-026-01295-9.","journal-title":"Drugs Aging"},{"issue":"5","key":"1733_CR15","doi-asserted-by":"publisher","first-page":"1573","DOI":"10.1007\/s41999-025-01215-x","volume":"16","author":"PA Rochon","year":"2025","unstructured":"Rochon PA, O\u2019Mahony D, Cherubini A, et al. International expert panel\u2019s potentially inappropriate prescribing cascades (PIPC) list. Eur Geriatr Med. 2025;16(5):1573\u201384. https:\/\/doi.org\/10.1007\/s41999-025-01215-x.","journal-title":"Eur Geriatr Med"},{"key":"1733_CR16","unstructured":"MedDRA. MedDRA Hierarchy. https:\/\/www.meddra.org\/how-to-use\/basics\/hierarchy. Accessed 5 Mar 2025."},{"key":"1733_CR17","unstructured":"MedBrains. Pharmacovigilance Polaris. https:\/\/www.medbrains.it\/en\/products\/pharmacovigilance-polaris.html. Accessed 7 Apr 2025."},{"key":"1733_CR18","doi-asserted-by":"publisher","unstructured":"Zorzi M, Combi C, Lora R, Pagliarini M, Moretti U. Automagically encoding adverse drug reactions in MedDRA. In: 2015 International conference on healthcare informatics (ICHI). Los Alamitos: IEEE Computer Society; 2015. p. 90\u20139. https:\/\/doi.org\/10.1109\/ICHI.2015.18.","DOI":"10.1109\/ICHI.2015.18"},{"key":"1733_CR19","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1016\/j.jbi.2018.07.001","volume":"84","author":"C Combi","year":"2018","unstructured":"Combi C, Zorzi M, Pozzani G, Moretti U, Arzenton E. From narrative descriptions to MedDRA: automagically encoding adverse drug reactions. J Biomed Inform. 2018;84:184\u201399. https:\/\/doi.org\/10.1016\/j.jbi.2018.07.001.","journal-title":"J Biomed Inform"},{"key":"1733_CR20","unstructured":"MedBrains. MagiCoder Pro. https:\/\/www.medbrains.it\/en\/products\/magicoder-pro.html. Accessed 7 Apr 2025."},{"issue":"10","key":"1733_CR21","doi-asserted-by":"publisher","first-page":"2170","DOI":"10.1002\/sim.2677","volume":"26","author":"ND Mercaldo","year":"2007","unstructured":"Mercaldo ND, Lau KF, Zhou XH. Confidence intervals for predictive values with an emphasis to case-control studies. Stat Med. 2007;26(10):2170\u201383. https:\/\/doi.org\/10.1002\/sim.2677.","journal-title":"Stat Med"},{"issue":"16","key":"1733_CR22","doi-asserted-by":"publisher","first-page":"2537","DOI":"10.1002\/sim.1836","volume":"23","author":"J Li","year":"2004","unstructured":"Li J, Fine J. On sample size for sensitivity and specificity in prospective diagnostic accuracy studies. Stat Med. 2004;23(16):2537\u201350. https:\/\/doi.org\/10.1002\/sim.1836.","journal-title":"Stat Med"},{"issue":"6","key":"1733_CR23","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.86996","volume":"17","author":"M Takizawa","year":"2025","unstructured":"Takizawa M, Nakayama N, Ohishi Y, et al. Physicians\u2019 perspectives on prescription alerts: a journey towards reducing fatigue. Cureus. 2025;17(6):e86996. https:\/\/doi.org\/10.7759\/cureus.86996.","journal-title":"Cureus"},{"key":"1733_CR24","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.ijmedinf.2017.08.008","volume":"107","author":"Y Zenziper Straichman","year":"2017","unstructured":"Zenziper Straichman Y, Kurnik D, Matok I, et al. Prescriber response to computerized drug alerts for electronic prescriptions among hospitalized patients. Int J Med Inform. 2017;107:70\u20135. https:\/\/doi.org\/10.1016\/j.ijmedinf.2017.08.008.","journal-title":"Int J Med Inform"},{"issue":"1","key":"1733_CR25","doi-asserted-by":"publisher","DOI":"10.2196\/humanfactors.5320","volume":"3","author":"R Wipfli","year":"2016","unstructured":"Wipfli R, Ehrler F, Bediang G, B\u00e9trancourt M, Lovis C. How regrouping alerts in computerized physician order entry layout influences physicians\u2019 prescription behavior: results of a crossover randomized trial. JMIR Hum Factors. 2016;3(1):e15. https:\/\/doi.org\/10.2196\/humanfactors.5320.","journal-title":"JMIR Hum Factors"},{"issue":"7","key":"1733_CR26","doi-asserted-by":"publisher","DOI":"10.1093\/ageing\/afac138","volume":"51","author":"D O\u2019Mahony","year":"2022","unstructured":"O\u2019Mahony D, Rochon PA. Prescribing cascades: we see only what we look for, we look for only what we know. Age Ageing. 2022;51(7):afac138. https:\/\/doi.org\/10.1093\/ageing\/afac138.","journal-title":"Age Ageing"},{"issue":"2","key":"1733_CR27","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/j.therap.2023.09.010","volume":"79","author":"MA Heurtebize","year":"2024","unstructured":"Heurtebize MA, Faillie JL. Drug-induced hyperglycemia and diabetes. Therapie. 2024;79(2):221\u201338. https:\/\/doi.org\/10.1016\/j.therap.2023.09.010.","journal-title":"Therapie"},{"issue":"12","key":"1733_CR28","doi-asserted-by":"publisher","first-page":"1042","DOI":"10.1016\/j.sapharm.2025.07.001","volume":"21","author":"K Dalton","year":"2025","unstructured":"Dalton K, Evrard P, Moriarty F, et al. How are prescribing cascades defined in the literature? A scoping review. Res Soc Adm Pharm. 2025;21(12):1042\u20139. https:\/\/doi.org\/10.1016\/j.sapharm.2025.07.001.","journal-title":"Res Social Adm Pharm"},{"issue":"10","key":"1733_CR29","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1007\/s40266-022-00964-9","volume":"39","author":"LM McCarthy","year":"2022","unstructured":"McCarthy LM, Savage R, Dalton K, et al. ThinkCascades: a tool for identifying clinically important prescribing cascades affecting older people. Drugs Aging. 2022;39(10):829\u201340. https:\/\/doi.org\/10.1007\/s40266-022-00964-9.","journal-title":"Drugs Aging"},{"issue":"12","key":"1733_CR30","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.1007\/s40266-023-01072-y","volume":"40","author":"O Adrien","year":"2023","unstructured":"Adrien O, Mohammad AK, Hugtenburg JG, et al. Prescribing cascades with recommendations to prevent or reverse them: a systematic review. Drugs Aging. 2023;40(12):1085\u2013100. https:\/\/doi.org\/10.1007\/s40266-023-01072-y.","journal-title":"Drugs Aging"},{"key":"1733_CR31","unstructured":"MagiCoder Pro. https:\/\/www.magicoderpro.com\/. Accessed 24 Mar 2026."}],"container-title":["Drug Safety"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40264-026-01733-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40264-026-01733-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40264-026-01733-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T16:56:36Z","timestamp":1789836996000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40264-026-01733-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,19]]},"references-count":31,"alternative-id":["1733"],"URL":"https:\/\/doi.org\/10.1007\/s40264-026-01733-y","relation":{},"ISSN":["0114-5916","1179-1942"],"issn-type":[{"value":"0114-5916","type":"print"},{"value":"1179-1942","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,19]]},"assertion":[{"value":"13 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 September 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Gianluca Trifir\u00f2 has served, over the last 3\u00a0years, on advisory boards\/seminars funded by Sanofi, MSD, Eli Lilly, Sobi, Celgene, Daiichi Sankyo, Novo Nordisk, Gilead, and Amgen on topics not related to content of this paper; he is also a scientific coordinator of the academic spin-off \u201cINSPIRE srl,\u201d which has received funding from several pharmaceutical companies (Kiowa Kirin, Shionogi, Shire, Novo Nordisk, and Daiichi Sankyo) for conducting observational studies and additional consultancy services on topics not related to content of this paper. Additionally, he is currently a consultant for Viatris in a legal case concerning an adverse reaction to sertraline. None of these listed activities are related to the topic of the article. Gianluca Trifir\u00f2 is an Editorial Board member of\n                      Drug Safety\n                      . Gianluca Trifir\u00f2 was not involved in the selection of peer reviewers for the manuscript nor in any of the subsequent editorial decisions. The other authors have no conflict of interest to declare.","order":1,"name":"Ethics","label":"Conflicts of Interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable. This study did not use personal data.","order":2,"name":"Ethics","label":"Ethics Approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":3,"name":"Ethics","label":"Consent to Participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":4,"name":"Ethics","label":"Consent for Publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Massimo Carollo: writing\u2014original draft, writing\u2014review and editing, data curation. Anna Forti: writing\u2014review and editing, data curation. Salvatore Crisafulli: writing\u2014original draft, writing\u2014review and editing. Luca L\u2019Abbate: data curation and analysis. Irene Cristini: writing\u2014original draft, writing\u2014review and editing. Federica Soardo: writing\u2014review and editing, data curation. Marilisa Giustina Stano: writing\u2014review and editing, data curation. David Bellantuono: writing\u2014review and editing. Davide Benetti: writing\u2014review and editing, data curation. Riccardo Lora: writing\u2014review and editing, data curation, conceptualization. Gianluca Trifir\u00f2: writing\u2014review and editing, validation, supervision, conceptualization.\u00a0All authors read and approved the final version.","order":5,"name":"Ethics","label":"Authors\u2019 Contribution","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The reference list and algorithm outputs supporting the findings of this study are provided in the ESM, Online Resource Tables\u00a0\n                      \n                      and\n                      \n                      . The Italian Summaries of Product Characteristics used as source documents are publicly available from the Italian Medicines Agency. Additional data are available from the corresponding author upon reasonable request.","order":6,"name":"Ethics","label":"Availability of Data and Material","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The source code is not publicly available because it is integrated into the Prescribing INappropriateness Assessment (PINA) software, which is currently under development. The algorithmic logic and the four semantic-matching configurations evaluated in this study are described in the Sect.\u00a02. Further information is available from the corresponding author upon reasonable request.","order":7,"name":"Ethics","label":"Code Availability","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"No AI tools were used.","order":8,"name":"Ethics","label":"AI Use","group":{"name":"EthicsHeading","label":"Declarations"}}]}}